TLDRocket
Sign in

Anthropic

112 summarised stories about Anthropic, each linking back to the original source. Browse all topics →

Tuesday, 30 June 2026

Claude Science is Anthropic’s newest flagship product

MIT Technology Review AI 2 weeks ago

Anthropic launched Claude Science, a standalone product designed to autonomously conduct scientific research tasks in computational biology and drug development, available to all paid Claude subscribers. The system can execute work comparable to a second-year graduate student and integrates with tools for genetics, chemistry, and protein biology, as demonstrated when it identified drug candidates for phenylketonuria. Anthropic will use Claude Science for its own drug research on neglected diseases while competing with Google DeepMind's dominance in AI for science, particularly after researcher John Jumper recently left DeepMind to join Anthropic.

NVIDIA BioNeMo Agent Toolkit Brings Accelerated AI to Life Sciences Researchers in Claude Science

NVIDIA 2 weeks ago

NVIDIA released the BioNeMo Agent Toolkit, which integrates with Anthropic's Claude Science to let life sciences researchers run accelerated computational workflows through natural language commands. The toolkit includes accelerated tools like RAPIDS-singlecell that compress a 1.3-million-cell workflow from 52 minutes to 25 seconds, and nvMolKit that accelerates cheminformatics operations by up to 3,000x. Scientists can now access NVIDIA's accelerated models and libraries directly within Claude Science's conversational environment, with 18 of the top 20 pharmaceutical companies already using BioNeMo.